bpc 157 safety evidence human trials BPC-157 for athletes and injury treatment: Science, safety, and legal concerns BPC-157 and the Brain-Gut Axis:

Starting at lower doses allows assessment of individual tolerance and response before potentially increasing the dose

Researchers should note that clinical studies on Fragment 176-191 to date have not involved administration via subcutaneous injection, but have employed infusion instead, as four escalating single doses of 25mcg 400mcg/kg, with a washout week between each administration [1]

If you are using something known to impact estrogen or prolactin, have a plan and the necessary ancillary compounds on hand to manage those potential side effects

So it's time to consider the pluses and minuses of getting the vaccine

Its pretty locally acting, and I would use it on just about anybody

Entrance to Huacachina Oasis